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Results: CAD was detected by CA in 31 (39%) of the patients (3 or more vessels, 10, 2 
vessels, 5 and, 1 vessel, 16 cases). The prevalences of MI, stroke and diabetes were 
higher among patients with CAD (p< 0.05). Age, gender, race, time on dialysis, BMI, 
blood pressure, serum lipids, hematocnt, LVMI, ejection fraction, smoking and angina did 
not discriminate the groups. The sensitivity, specificity, and positive and negative predic- 
tive values of the tests (assuming a prevalence of 39% of CAD) were the following. DSE: 
41,93, 78 and 71%; SPECT: 30, 98, 90 and 69 %, respectively. The combined use of the 
tests did not improve significantly the results. After 36 + 20 months, there were 3 (6.1%) 
major cardiac events among patients with normal coronaries or nonsignificant CAD and 9 
(29%) among patients with CAD (p= 0.004). Altered DSE and/or SPECT were not predic- 
tors of major cardiac events. 
Conclusions: DSE and SPECT presented good specificity but low sensitivity and nega- 
tive predictive values. In contrast with CA, they also did not correlate with the occurrence 
of major cardiac events. We conclude that, among high-risk RTC, DSE and SPECT can 
not be considered substitutes for CA in order to detect CAD and to assess cardiac risk. 
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(Cardiology), Exeter, United Kingdom. 
Background: Outcome data on new onset exertional angina (NOAP) in the community 
are largely limited to the Framingham Study, and pre-date the coronary revascularization 
era; contemporary outcome of NOAP in primary care is not known. Aim: to investigate 
long-term prognosis of NOAP in primary care compared with age and sex matched 
asymptomatic controls (CON) from the same population, 
Methods: In 1990-93, randomly selected primary care practices in Southampton, UK, 
with a population of 192,000, referred all patients presenting for the first time with sus- 
pected angina to a dedicated rapid access chest pain clinic. 
Results: A total of 110 consecutive patients with NOAP (Framingham definition), 
mean(SD)age 57(9.6) years, 64% male, and 110 healthy CON, mean(SD)age 57(9.3) 
years, 61% male, were prospectively followed-up for death from all causes, nonfatal 
myocardial infarction (MI), CABG and PTCA over a median of 8.2 years. Follow-up was 
99.5% complete. Event-free survival from death/MI was 73.2% for NOAP vs 93,2% for 
CON, log rank p<0,001 ; for the combined end-point of death/MI, CABG or PTCA (CE), it 
was 42.6% NOAP vs 93.2% CON, log rank p<0.001, For NOAP, annual event rates 
[%(SD)per year] were: all cause mortality 2.3(0.5), death/MI 3.9(0.7), and for CE 11(1.5); 
all event rates were higher in the first year compared with years 2-10 (risk ratio 4.5, 
p<0.001). Relative risk (95% CI) for NOAP vs CON was: all cause mortality, 
3.9(1.5,10.5), CE, 26.8(8.4,85.5). After eight years, 54% of surviving NOAP were symp- 
tom free. Of CON, 6% (6 of 98) reported chest pain. In multivariate analysis among 
NOAP, baseline symptom severity did not predict outcome; Bruce treadmill duration was 
independently associated with increased risk of the CE [RR 3.5, 95%CI 1.9,6.6]. With 
CABG/PTCA as a time dependent variable, a trend towards reduced risk of deatWMI [RR 
0.3(0.1,1.2) p=0.08] was observed. 
Conclusion: This is the first study to describe contemporary long-term outcome of 
NOAP in the community. Cardiac event rate was highest during the first year after pre- 
sentation, and was not predicted by baseline symptom severity; after eight years, less 
than a third of patients presenting with NOAP were free from a major cardiac event or 
symptoms. 
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Background: Based on population studies and subset analyses from randomized trials, 
diabetes has been associated with an increase in cardiovascular risk similar in magni- 
tude to the "secondary" risk associated with prior myocardial infarction (MI). The prog- 
nostic importance of diabetes compared with prior MI on outcomes among patients with 
documented coronary artery disease (CAD) remains unclear. 
Methods: To evaluate the relative influence of diabetes and prior MI on outcomes among 
patients with documented coronary artery disease in a large prospective cohort, we ana- 
lyzed data on 18,481 patients undergoing cardiac catheterization at Duke from 1986- 
t999 who had CAD, defined as >_1 epicardial artery with >-75% stenosis. 
Results: In this group, 4574 (24.7%) had DM, Patients with DM were older, heavier, 
more likely female, more likely to have a history of hypertension, hyperlipidemia, CHF, 
and less likely to smoke. Among the DM subset, 2534 (55.4%) had a prior MI compared 
with 8414 (60.5%) of patients without DM. Mean follow-up was 6.5 +/-4.2 years. In unad- 
justed analyses, DM alone was associated with a much worse prognosis compared with 
a history of MI alone. (Figure) There was no evidence of a DM by MI interaction (p=0.72). 
Conclusion: Among patients with documented coronary artery disease, diabetes is 
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associated with greater long-term risk than is a history of myocardial infarction. These 
findings underscore the importance of developing more effective therapeutic strategies 
among this high-risk population. 
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Background: Women with ischemic heart disease (IHD) are known to have poor out- 
comes compared to men. Previous studies have also suggested that the adverse prog- 
nosis associated with diabetes is greater in women. We sought to evaluate the prognosis 
associated with diabetes, in analyses stratified by sex, to determine if similar differences 
ere seen in an unsalected cohort of patients. 
Methods: Using APPROACH, a clinical data collection and follow-up initiative capturing 
all patients undergoing cardiac catheterization in Alberta, Canada, the relative signifi- 
cance of diabetes on long-term survival in men and women was evaluated; first in the 
general cohort with IHD, and then according to treatment strategy (medical therapy, per- 
cutaneous coronary intervention (PCI), or coronary artery bypass graft (CABG) surgery). 
Cox proportional hazard models were used to calculate the risk*adjusted hazard ratios 
(HR) for diabetes in men and women. 
Results: Women were more likely to have comorbidities such as diabetes, hypertension, 
cerebrovascular disease, and a history of heart failure (p<0.001). Mortality rates at one 
year were 4.7% in men (4.1% in non-diabetic patients and 7.4% in diabetic patients, 
n=13,152) and 6.8% in women (5.8% in non-diabetic patients and 9.6% in diabetic 
patients, n=4249, p<0.001 for sex comparison). When data were analysed for all patients 
we found that the HR associated with diabetes were 1.31 in men and 1.43 in woman. 
When we stratified according to treatment, the HR for diabetes in patients treated with 
PCI were 1.33 in men and 1.52 in women. HR for diabetes in patients treated with CABG 
were 1.23 in men and 1.28 in women, and for those treated medically were 1.34 in men 
and 1.42 in women. 
Conclusions: While women with IHD continue to have poor outcomes compared to 
men, in APPROACH we find only a slight sex difference in the prognostic importance of 
diabetes. However, we do find that the HR for diabetes differed most markedly in patients 
treated with PCI. Considering the finding in the BARI trial of poor prognosis with diabetes 
and PCI, our finding suggests that women with diabetes who undergo PCI may be a par- 
ticularly susceptible group. 
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Background: Neoptedn, a pterydine derivative secreted by activated macrophages, has 
been shown to be elevated in patients with acute coronary syndromes and is associated 
with complex stenosis morphology in patients with unstable angina. The aim of the 
present study was to examine the prognostic significance of increased serum neoptedn 
levels in patients with chronic stable angina. 
Methods and Results: We studied 307 patients (28% women, mean age 63 ± 9 ys) with 
chronic stable angina. Serum neoptedn was measured using a commercially available 
immunoassay (ELISA) kit in blood samples drawn at study entry. All patients were fol- 
lowed up for a mean period of 12 ± 3 months and during that period 54 patients (17.6%) 
developed at least one major adverse coronary event (MACE: Acute myocardial infarc- 
tion, episodes of unstable angina, emergency revascularisation or cardiac death). There 
was no statistically significant difference in the prevalence of demographic and clinical 
variables between patients with and without MACE. The mean serum neopterin levels 
among patients with and without MACE were 7.19 ± 3.66 and 5,85 ± 3.31 nmol/I respec- 
tively (p=0.009). A positive correlation was seen between serum neoptedn level and the 
occurence of MACE ( r = 0.15, p<0.01). Multiple logistic regression analysis also 
revealed that high neopterin levels were an independent predictor of future adverse 
events (p=0.03). 
Conclusions: Serum neopterin level is an independent predictor of major adverse core- 
nary events in patients with chronic stable angina. This marker of atherosclerotic disease 
activity may be a useful adjunct to the risk stratification strategies of patients with core- 
nary artery disease. 
